American Riviera
You are here:  Home  >  Biotech  >  Current Article

Amgen offers to acquire Nuevolution for $167 million

By   /   Wednesday, May 22nd, 2019  /   Comments Off on Amgen offers to acquire Nuevolution for $167 million

    Print       Email
Amgen, the $100 billion biotech giant based in Thousand Oaks, announced an all-cash offer May 22 to acquire Copenhagen-based research institute Nuevolution for $167 million. At $3.37 per share, the offer nearly triples the value of the stock, which closed May 21 at 12.1 Swedish krona, or $1.26 per share, on the Nasdaq Stockholm exchange.…


    This article is only available to Business Times subscribers
  • Subscribers: or REGISTER for complete digital access.
  • Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
  • Check the STATUS of your Subscription Account.
    Print       Email

You might also like...

Guilty pleas in perfume thefts as Ventura County authorities take action on retail crime

Read More →